Meet the Expert – Session 6 | 13:00-14:00 CET MOG antibody disease Michael Levy, USA |
|
Industry Sponsored Symposium | 15:30-16:30 CET
Current and Evolving Treatment of NMOSD in 2021
|
|
Meet the Expert: Roundtable Discussion | 18:45-19:30 CET
Treatment goals with current and emerging levodopa formulations Capsule: Levodopa pulsatility is associated with motor fluctuations. Formulations with lower fluctuation index have been developed. What is the evidence for treating OFF? Who should be treated? When and how should immediate release be switched to extended release formulations? Moderator: Rajesh Pahwa, USA
|
|
Meet the Expert: Roundtable Discussion | 19:30-20:15 CET
Subcutaneous apomorphine: current and emerging delivery Capsule: Recognition of OFF episodes in patients with OFF time can sometimes be difficult.. Deciding when to treat OFF episodes with an ON demand therapy can be clinically challenging . How to decide for each individual patient whether to adjust baseline treatment, or to use as needed additional oral or add a non-oral treatment? Moderator: Stuart Isaacson, USA
|
|
Meet the Expert: Roundtable Discussion | 20:15-21:00 CET
Clinical Use of Apomorphine sublingual film Capsule: ON demand treatment with apomorphine remains underutilized, despite demonstrated efficacy. Apomorphine sublingual film was recently approved in the US. Which patients should be considered? Which types of OFF respond to treatment? When and how should apomorphine sublingual film be initiated? Moderator: Stuart Isaacson, USA
|